The stock of Oscar Health Inc (NYSE:OSCR) last traded at $20.42, down -3.77%% from the previous session.
OSCR stock price is now 39.78% away from the 50-day moving average and 30.39% away from the 200-day moving average. The market capitalization of the company currently stands at $5.20B.
With the price target reduced from $20 to $16, Wells Fargo Downgraded its rating from Overweight to Equal Weight for Oscar Health Inc (NYSE: OSCR). On December 10, 2024, Jefferies recently initiated its ‘Underperform’ rating on the stock quoting a target price of $12, while ‘BofA Securities’ rates the stock as ‘Underperform’
In other news, RANMALI BOPITIYA, Officer bought 30,000 shares of the company’s stock on Jun 20 ’25. The stock was bought for $563,100 at an average price of $18.77. An SEC document containing details of the transaction can be found on the SEC’s website. On May 16 ’25, Former Officer ALESSANDREA QUANE bought 148,280 shares of the business’s stock. A total of $2,598,488 was incurred on buying the stock at an average price of $17.52. A total of 29.26% of the company’s stock is owned by insiders.
During the past 12 months, Oscar Health Inc has had a low of $11.20 and a high of $23.79. According to the stock market information, the enterprise value for the company is $2568179968, which is based on a 73.30 price-to-earnings ratio, a 0.47 price-to-earnings-growth ratio, and a beta of 1.73. The fifty day moving average price for OSCR is $14.6088 and a two-hundred day moving average price translates $15.6612 for the stock.
The latest earnings results from Oscar Health Inc (NYSE: OSCR) was released for 2025-03-31. The net profit margin was 1.22% and return on equity was 10.43% for OSCR. The company reported revenue of $3.05 billion for the quarter, compared to $2.14 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 42.2 percent.
